Nintx at Food Ingredients South America (FISA) 2025
- Nintx
- Aug 28
- 1 min read
Our Chief Development Officer, Miller Freitas, brought a perspective focused on precision medicine and the role of the gut microbiome in personalizing foods and treatments
During FISA 2025, the panel "Trends: The Use of New Technologies in Personalized Nutrition" highlighted innovations such as artificial intelligence (AI), 3D food printing, and therapies based on the gut microbiome. Miller Freitas brought a perspective focused on precision medicine and the role of the gut microbiome in personalized foods and treatments.
"We believe that natural foods will play an increasingly important role, especially for individuals with special needs. Brazilian biodiversity is an essential asset for our studies, and we are focused on better understanding how the microbiome affects the body's response to foods and medications."
To have access to the full content, check us out on LinkedIn.
